HCW Biologics Inc. Common Stock (HCWB) is a publicly traded Healthcare sector company. As of July 23, 2026, HCWB trades at $3.20 with a market cap of $5.40M and a P/E ratio of -0.43. HCWB moved -9.12% today. Year to date, HCWB is -42.56%; over the trailing twelve months it is -87.09%. Its 52-week range spans $1.50 to $247.20. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces HCWB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for HCWB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.20 |
| Market Cap | $5.40M |
| P/E Ratio | -0.43 |
| EPS | $-7.73 |
| Dividend Yield | 0.00% |
| 52-Week High | $247.20 |
| 52-Week Low | $1.50 |
| Volume | 45.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.55M |
| Net Income | $-2.29M |
| Gross Margin | 99.89% |
1 analysts cover HCWB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.